| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
28,490 |
25,929 |
$4.71M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,768 |
7,273 |
$4.15M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,635 |
15,214 |
$3.74M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,723 |
17,552 |
$2.55M |
| G0378 |
Hospital observation service, per hour |
12,178 |
5,874 |
$2.25M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,464 |
4,003 |
$1.62M |
| 95811 |
|
1,823 |
1,765 |
$1.04M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,703 |
2,536 |
$906K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,856 |
6,227 |
$903K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,849 |
2,654 |
$709K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,433 |
3,295 |
$678K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,810 |
6,334 |
$509K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,622 |
7,256 |
$427K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,376 |
1,298 |
$376K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,908 |
1,844 |
$342K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
598 |
576 |
$315K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,355 |
2,289 |
$283K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17,013 |
13,707 |
$269K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,179 |
3,946 |
$242K |
| 43235 |
|
771 |
736 |
$238K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
687 |
663 |
$217K |
| 70498 |
|
558 |
523 |
$172K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,424 |
1,326 |
$157K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,572 |
2,426 |
$128K |
| 80053 |
Comprehensive metabolic panel |
47,426 |
37,523 |
$127K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,316 |
3,180 |
$115K |
| 49083 |
|
521 |
210 |
$101K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
120 |
50 |
$89K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
95 |
93 |
$86K |
| 97803 |
|
2,332 |
2,218 |
$74K |
| 99201 |
|
431 |
409 |
$59K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,814 |
1,184 |
$57K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,293 |
2,404 |
$56K |
| 70496 |
|
669 |
628 |
$56K |
| 93971 |
|
1,539 |
1,437 |
$53K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,897 |
3,622 |
$44K |
| 93970 |
|
205 |
193 |
$41K |
| 72131 |
|
275 |
260 |
$40K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
21,438 |
18,980 |
$39K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,921 |
5,701 |
$35K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
519 |
498 |
$32K |
| 71046 |
Radiologic examination, chest; 2 views |
7,467 |
7,136 |
$29K |
| 73630 |
|
801 |
732 |
$28K |
| 84702 |
|
3,452 |
3,120 |
$26K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,114 |
7,461 |
$21K |
| 73130 |
|
302 |
272 |
$17K |
| 73610 |
|
283 |
267 |
$17K |
| 73562 |
|
373 |
337 |
$17K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
152 |
143 |
$16K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
14 |
14 |
$15K |
| 70486 |
|
95 |
94 |
$15K |
| 59025 |
Fetal non-stress test |
6,928 |
5,028 |
$12K |
| 96376 |
|
7,277 |
4,569 |
$11K |
| 97802 |
|
322 |
308 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,463 |
18,381 |
$11K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,282 |
3,280 |
$10K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
130 |
124 |
$10K |
| 97804 |
|
192 |
186 |
$10K |
| 88304 |
|
673 |
639 |
$9K |
| 88307 |
|
192 |
185 |
$8K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,462 |
2,317 |
$8K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,414 |
2,283 |
$8K |
| 93976 |
|
3,501 |
3,229 |
$7K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
130 |
119 |
$6K |
| 74174 |
|
17 |
14 |
$6K |
| 99215 |
Prolong outpt/office vis |
236 |
234 |
$6K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
208 |
184 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
26,100 |
21,111 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
98 |
98 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,769 |
2,656 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
6,961 |
6,598 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
49,548 |
37,910 |
$4K |
| C1769 |
Guide wire |
1,544 |
1,390 |
$4K |
| 83690 |
|
17,476 |
15,656 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
72 |
72 |
$4K |
| 73110 |
|
192 |
168 |
$4K |
| 73030 |
|
438 |
389 |
$3K |
| J3490 |
Unclassified drugs |
37,116 |
17,880 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,574 |
6,329 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,345 |
1,273 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,115 |
1,012 |
$3K |
| 87040 |
|
4,384 |
3,669 |
$3K |
| 84703 |
|
12,683 |
11,629 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,812 |
2,836 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
465 |
431 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
13,142 |
12,000 |
$3K |
| 82248 |
|
439 |
289 |
$2K |
| 80061 |
Lipid panel |
2,188 |
1,984 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,539 |
2,373 |
$2K |
| 76830 |
Ultrasound, transvaginal |
1,852 |
1,735 |
$2K |
| A9270 |
Non-covered item or service |
12,140 |
4,574 |
$2K |
| 87070 |
|
1,183 |
769 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,458 |
5,045 |
$2K |
| 81001 |
|
19,430 |
17,668 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
76 |
64 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
11,501 |
10,433 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
55,513 |
39,178 |
$1K |
| 84484 |
|
14,746 |
11,924 |
$1K |
| 74018 |
|
196 |
174 |
$1K |
| 83735 |
|
12,661 |
8,768 |
$1K |
| 83605 |
|
7,306 |
6,444 |
$1K |
| 86850 |
|
3,480 |
3,126 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
30 |
26 |
$1K |
| 83880 |
|
3,624 |
3,330 |
$909.49 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
13 |
12 |
$857.90 |
| 76942 |
|
15 |
15 |
$831.46 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,187 |
1,149 |
$730.43 |
| 94010 |
|
82 |
80 |
$643.20 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20,575 |
16,776 |
$637.17 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,143 |
1,100 |
$627.41 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
1,368 |
929 |
$605.02 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,361 |
1,304 |
$570.73 |
| 76801 |
|
721 |
657 |
$536.43 |
| 85379 |
|
3,240 |
3,049 |
$514.66 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
12,274 |
10,912 |
$471.45 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
750 |
579 |
$444.56 |
| 82728 |
|
405 |
356 |
$417.10 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,211 |
8,110 |
$395.57 |
| 81025 |
|
4,250 |
4,079 |
$387.72 |
| 85027 |
|
6,781 |
5,322 |
$386.42 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,412 |
1,113 |
$380.47 |
| J2704 |
Injection, propofol, 10 mg |
9,407 |
8,801 |
$369.60 |
| G0379 |
Direct admission of patient for hospital observation care |
13 |
13 |
$360.59 |
| 86635 |
|
45 |
38 |
$354.48 |
| 87186 |
|
1,714 |
1,581 |
$347.62 |
| 85730 |
|
9,656 |
8,110 |
$338.72 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
10,701 |
7,478 |
$273.28 |
| 81003 |
|
7,461 |
6,976 |
$262.19 |
| 82962 |
|
12,699 |
6,899 |
$258.99 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,581 |
6,099 |
$238.40 |
| 85610 |
|
12,997 |
10,829 |
$231.35 |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,181 |
1,302 |
$212.31 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
275 |
254 |
$210.70 |
| 87077 |
|
2,172 |
1,995 |
$206.36 |
| 71250 |
|
14 |
13 |
$193.41 |
| J2060 |
Injection, lorazepam, 2 mg |
2,530 |
2,041 |
$176.35 |
| 84100 |
|
2,659 |
2,167 |
$175.42 |
| 90715 |
|
253 |
247 |
$164.53 |
| 87634 |
|
911 |
880 |
$160.16 |
| 87400 |
|
1,244 |
1,181 |
$149.73 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,659 |
1,400 |
$146.85 |
| 82803 |
|
352 |
317 |
$131.74 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,505 |
3,773 |
$117.08 |
| 86900 |
|
4,010 |
3,563 |
$101.74 |
| 86141 |
|
1,563 |
1,425 |
$100.96 |
| 82550 |
|
3,063 |
2,684 |
$97.51 |
| 86308 |
|
39 |
38 |
$88.96 |
| 86901 |
|
4,006 |
3,562 |
$87.85 |
| 84145 |
|
1,134 |
1,031 |
$87.82 |
| 87420 |
|
324 |
314 |
$81.65 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,785 |
1,915 |
$76.09 |
| 97162 |
|
488 |
455 |
$65.75 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,589 |
2,415 |
$64.88 |
| 87075 |
|
107 |
51 |
$64.33 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,200 |
2,150 |
$60.13 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
386 |
310 |
$59.62 |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,571 |
828 |
$56.79 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,407 |
1,276 |
$54.94 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
495 |
373 |
$54.75 |
| 97161 |
|
221 |
205 |
$54.39 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,456 |
2,273 |
$52.96 |
| 85007 |
|
2,960 |
2,469 |
$45.74 |
| 86592 |
|
274 |
246 |
$33.09 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
642 |
605 |
$25.05 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
106 |
95 |
$23.40 |
| 84132 |
|
359 |
289 |
$20.31 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,916 |
3,559 |
$20.13 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,732 |
4,314 |
$18.91 |
| 97166 |
|
282 |
259 |
$18.19 |
| 85652 |
|
931 |
847 |
$13.86 |
| J1956 |
Injection, levofloxacin, 250 mg |
241 |
181 |
$12.83 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
553 |
417 |
$12.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,910 |
7,833 |
$10.89 |
| Q0114 |
Fern test |
636 |
570 |
$9.98 |
| 84439 |
|
150 |
142 |
$9.14 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
345 |
299 |
$7.98 |
| 87210 |
|
103 |
100 |
$7.67 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
747 |
704 |
$5.79 |
| 82570 |
|
796 |
675 |
$5.31 |
| J1815 |
Injection, insulin, per 5 units |
3,006 |
1,427 |
$4.16 |
| 84550 |
|
798 |
661 |
$4.01 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,590 |
2,248 |
$3.04 |
| J1630 |
Injection, haloperidol, up to 5 mg |
321 |
287 |
$0.94 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
772 |
726 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
836 |
469 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
1,028 |
952 |
$0.00 |
| 82150 |
|
187 |
166 |
$0.00 |
| 82553 |
|
95 |
68 |
$0.00 |
| 82607 |
|
296 |
279 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
636 |
582 |
$0.00 |
| 88342 |
|
697 |
655 |
$0.00 |
| 83615 |
|
570 |
489 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
160 |
127 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
114 |
105 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
60 |
51 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
123 |
107 |
$0.00 |
| 82746 |
|
252 |
241 |
$0.00 |
| 87205 |
|
1,420 |
937 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
51 |
49 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
160 |
127 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
290 |
267 |
$0.00 |
| 90686 |
|
152 |
143 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
217 |
209 |
$0.00 |
| 81005 |
|
219 |
202 |
$0.00 |
| 97535 |
Self-care/home management training, each 15 minutes |
201 |
155 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
253 |
242 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
157 |
91 |
$0.00 |
| 72128 |
|
25 |
24 |
$0.00 |
| 97165 |
|
42 |
39 |
$0.00 |
| 87428 |
|
103 |
102 |
$0.00 |
| J2305 |
Injection, nitroglycerin, 5 mg |
15 |
14 |
$0.00 |
| 92523 |
|
15 |
14 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
15 |
14 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
14 |
13 |
$0.00 |
| 99152 |
|
781 |
723 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
30 |
24 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
34 |
25 |
$0.00 |
| C1729 |
Catheter, drainage |
1,110 |
455 |
$0.00 |
| 83540 |
|
210 |
200 |
$0.00 |
| 89051 |
|
274 |
153 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
205 |
165 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
739 |
683 |
$0.00 |
| 82140 |
|
75 |
64 |
$0.00 |
| 84156 |
|
889 |
693 |
$0.00 |
| 85384 |
|
354 |
308 |
$0.00 |
| 84466 |
|
208 |
199 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,147 |
1,071 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
350 |
328 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
50 |
47 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
204 |
165 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
14 |
12 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
134 |
87 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
31 |
24 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
12 |
12 |
$0.00 |
| 92610 |
|
51 |
45 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
133 |
80 |
$0.00 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
25 |
25 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
16 |
13 |
$0.00 |
| 84425 |
|
13 |
13 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
32 |
31 |
$0.00 |
| 83970 |
|
29 |
28 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
35 |
25 |
$0.00 |
| 82010 |
|
40 |
36 |
$0.00 |
| 73590 |
|
13 |
12 |
$0.00 |
| Q9961 |
High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml |
43 |
37 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
15 |
15 |
$0.00 |
| 97163 |
|
69 |
60 |
$0.00 |
| 93017 |
|
13 |
12 |
$0.00 |
| C1758 |
Catheter, ureteral |
13 |
12 |
$0.00 |
| 82565 |
|
12 |
12 |
$0.00 |